Pregnancy outcomes and risk of endometrial cancer: A pooled analysis of individual participant data in the Epidemiology of Endometrial Cancer Consortium.
endometrial cancer
induced abortion
miscarriage
parity
sex of offspring
Journal
International journal of cancer
ISSN: 1097-0215
Titre abrégé: Int J Cancer
Pays: United States
ID NLM: 0042124
Informations de publication
Date de publication:
01 05 2021
01 05 2021
Historique:
revised:
27
09
2020
received:
23
06
2020
accepted:
01
10
2020
pubmed:
27
10
2020
medline:
8
9
2021
entrez:
26
10
2020
Statut:
ppublish
Résumé
A full-term pregnancy is associated with reduced endometrial cancer risk; however, whether the effect of additional pregnancies is independent of age at last pregnancy is unknown. The associations between other pregnancy-related factors and endometrial cancer risk are less clear. We pooled individual participant data from 11 cohort and 19 case-control studies participating in the Epidemiology of Endometrial Cancer Consortium (E2C2) including 16 986 women with endometrial cancer and 39 538 control women. We used one- and two-stage meta-analytic approaches to estimate pooled odds ratios (ORs) for the association between exposures and endometrial cancer risk. Ever having a full-term pregnancy was associated with a 41% reduction in risk of endometrial cancer compared to never having a full-term pregnancy (OR = 0.59, 95% confidence interval [CI] 0.56-0.63). The risk reduction appeared the greatest for the first full-term pregnancy (OR = 0.78, 95% CI 0.72-0.84), with a further ~15% reduction per pregnancy up to eight pregnancies (OR = 0.20, 95% CI 0.14-0.28) that was independent of age at last full-term pregnancy. Incomplete pregnancy was also associated with decreased endometrial cancer risk (7%-9% reduction per pregnancy). Twin births appeared to have the same effect as singleton pregnancies. Our pooled analysis shows that, while the magnitude of the risk reduction is greater for a full-term pregnancy than an incomplete pregnancy, each additional pregnancy is associated with further reduction in endometrial cancer risk, independent of age at last full-term pregnancy. These results suggest that the very high progesterone level in the last trimester of pregnancy is not the sole explanation for the protective effect of pregnancy.
Identifiants
pubmed: 33105052
doi: 10.1002/ijc.33360
pmc: PMC7969437
mid: NIHMS1671172
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, N.I.H., Intramural
Research Support, Non-U.S. Gov't
Research Support, U.S. Gov't, P.H.S.
Langues
eng
Sous-ensembles de citation
IM
Pagination
2068-2078Subventions
Organisme : U.S. Public Health Service
ID : R01-CA-55700
Organisme : NCI NIH HHS
ID : R03 CA096400
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR001863
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA105212
Pays : United States
Organisme : NCI NIH HHS
ID : N01-CN-05223
Pays : United States
Organisme : NCI NIH HHS
ID : P30CA016056
Pays : United States
Organisme : NCI NIH HHS
ID : R03 CA169888
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA48774
Pays : United States
Organisme : NCI NIH HHS
ID : K05 CA092002
Pays : United States
Organisme : U.S. Public Health Service
ID : P01-CA-33619
Organisme : NCI NIH HHS
ID : P30 CA016087
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA118100
Pays : United States
Organisme : NCI NIH HHS
ID : N01-CN-55424
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA016056
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA087538
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA39742
Pays : United States
Organisme : NCI NIH HHS
ID : P01 CA087969
Pays : United States
Organisme : NCI NIH HHS
ID : U01 CA164974
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA048737
Pays : United States
Organisme : NIH HHS
ID : R01 CA74877
Pays : United States
Organisme : NCI NIH HHS
ID : U01 CA182934
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA058598
Pays : United States
Organisme : NCI NIH HHS
ID : 2R01 CA082838
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA77398
Pays : United States
Organisme : NCI NIH HHS
ID : P30CA118100
Pays : United States
Organisme : NCI NIH HHS
ID : R35 CA39779
Pays : United States
Organisme : U.S. Public Health Service
ID : R01-CA-58598
Organisme : NIEHS NIH HHS
ID : P30 ES000260
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA092585
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA082838
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA008748
Pays : United States
Organisme : NCI NIH HHS
ID : R03 CA135632
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA058420
Pays : United States
Organisme : NCI NIH HHS
ID : CA11535
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA047749
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA014089
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA039742
Pays : United States
Organisme : NCI NIH HHS
ID : P01 CA87969
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA083918
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA47749
Pays : United States
Organisme : Intramural NIH HHS
ID : Z99 CA999999
Pays : United States
Organisme : NCI NIH HHS
ID : P01 CA033619
Pays : United States
Organisme : U.S. Public Health Service
ID : P20-CA-57113
Organisme : NCI NIH HHS
ID : R01 CA75977
Pays : United States
Organisme : NCI NIH HHS
ID : P01 CA077596
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA098346
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA077398
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA081212
Pays : United States
Organisme : CIHR
Pays : Canada
Organisme : NCI NIH HHS
ID : P01-CA77596
Pays : United States
Organisme : NICHD NIH HHS
ID : N01 HD023166
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA14089
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA071789
Pays : United States
Organisme : NCI NIH HHS
ID : U01 CA164973
Pays : United States
Informations de copyright
© 2020 UICC.
Références
Cancer Epidemiol Biomarkers Prev. 2004 Aug;13(8):1296-301
pubmed: 15298949
Eur J Cancer Prev. 2002 Jun;11(3):283-93
pubmed: 12131662
Eur J Cancer. 2011 Mar;47(4):586-91
pubmed: 21055917
Int J Cancer. 2004 Feb 10;108(4):613-9
pubmed: 14696129
PLoS One. 2012;7(10):e46042
pubmed: 23056232
Am J Epidemiol. 2012 Aug 15;176(4):269-78
pubmed: 22831825
Am J Epidemiol. 2006 Oct 15;164(8):775-86
pubmed: 16997897
Am J Obstet Gynecol. 1991 Feb;164(2):522-7
pubmed: 1992695
Am J Obstet Gynecol. 1992 Nov;167(5):1317-25
pubmed: 1442985
Int J Cancer. 2019 Oct 1;145(7):1719-1730
pubmed: 30387875
BMJ. 2019 Aug 14;366:l4693
pubmed: 31412996
Int J Cancer. 1998 Jun 10;76(6):784-6
pubmed: 9626340
BMC Pregnancy Childbirth. 2018 Sep 5;18(1):360
pubmed: 30185145
Epidemiology. 2011 Sep;22(5):638-45
pubmed: 21691206
Br J Cancer. 1988 Feb;57(2):205-12
pubmed: 3358913
Am J Obstet Gynecol. 2000 Jan;182(1 Pt 1):23-9
pubmed: 10649152
J Clin Oncol. 2013 Jul 10;31(20):2607-18
pubmed: 23733771
Oncology. 1996 Sep-Oct;53(5):354-9
pubmed: 8784467
Cancer Causes Control. 1999 Feb;10(1):43-9
pubmed: 10334641
Obstet Gynecol. 2011 Nov;118(5):1029-1036
pubmed: 22015870
Int J Cancer. 2010 Jul 15;127(2):442-51
pubmed: 19924816
Acta Obstet Gynecol Scand. 2008;87(11):1123-8
pubmed: 18951203
Int J Cancer. 2002 Apr 20;98(6):912-5
pubmed: 11948472
BMC Pregnancy Childbirth. 2016 Jul 04;16(1):146
pubmed: 27377060
Endocr Rev. 2013 Feb;34(1):130-62
pubmed: 23303565
Cancer Causes Control. 1998 Dec;9(6):653-7
pubmed: 10189052
Am J Epidemiol. 1996 Jun 15;143(12):1195-202
pubmed: 8651218
Br J Cancer. 2007 May 7;96(9):1450-6
pubmed: 17426703
J Natl Cancer Inst. 1985 Apr;74(4):741-5
pubmed: 3857369
BMJ. 2003 Sep 6;327(7414):557-60
pubmed: 12958120